| |
| |
|
| Insider
Information: |
Barris Peter J |
| Relationship: |
Director |
| City: |
Baltimore |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
61 |
|
| Direct
Shares |
374,379 |
|
|
Indirect Shares
|
283,825,989 |
|
|
| Direct
Value |
$4,560,322 |
|
|
|
Indirect Value
|
$1,355,812,700 |
|
|
| Total
Shares |
284,200,368 |
|
|
| Total
Value |
$1,360,373,022 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -37.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Welltek Incorporated |
WTKND |
Former 10% Owner |
|
0 |
2004-09-28 |
14,470 |
Premium* |
|
|
Aradigm Corp |
ARDM |
10% Owner |
2003-12-11 |
0 |
2004-02-20 |
0 |
Premium* |
|
|
FoxHollow Technologies |
FOXH |
Former 10% Owner |
2004-11-02 |
0 |
2004-11-02 |
1,804,462 |
Premium* |
|
|
DZS Inc |
DZSI |
10% Owner |
2005-02-10 |
0 |
2008-03-10 |
12,051,646 |
Premium* |
|
|
Occam Networks Inc |
OCNW |
10% Owner |
2006-04-06 |
0 |
2006-04-07 |
0 |
Premium* |
|
|
Gyre Therapeutics |
GYRE |
10% Owner |
2006-04-12 |
0 |
2013-12-05 |
4,563,512 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2009-01-30 |
2,083,426 |
Premium* |
|
|
Vonage Holdings Corp |
VG |
Director |
2012-07-01 |
121,640 |
2012-07-01 |
11,752,903 |
Premium* |
|
|
Innerworkings Inc |
INWK |
Director |
2012-05-30 |
35,549 |
2012-05-30 |
4,529,190 |
Premium* |
|
|
Amicus Therapeutics Inc |
FOLD |
10% Owner |
2007-06-05 |
0 |
2007-07-25 |
4,510,340 |
Premium* |
|
|
Inteliquent Inc |
IQNT |
Director |
2011-11-16 |
27,126 |
2009-06-10 |
0 |
Premium* |
|
|
Echo Global Logistics Inc |
ECHO |
Director |
|
0 |
2012-03-05 |
0 |
Premium* |
|
|
Financial Engines, Inc. |
FNGN |
10% Owner |
|
0 |
2010-08-30 |
3,481,941 |
Premium* |
|
|
Groupon, Inc. |
GRPN |
Director |
2022-06-15 |
24,614 |
2022-06-15 |
39,933 |
Premium* |
|
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
0 |
2013-06-03 |
2,483 |
Premium* |
|
|
Millennial Media Inc |
MM |
10% Owner |
2012-04-03 |
0 |
2012-10-29 |
8,196,614 |
Premium* |
|
|
Tesaro, Inc. |
TSRO |
10% Owner |
2012-07-03 |
0 |
2019-01-22 |
0 |
Premium* |
|
|
Hyperion Therapeutics Inc |
HPTX |
10% Owner |
|
0 |
2015-05-07 |
0 |
Premium* |
|
|
Audience Inc |
ADNC |
10% Owner |
2013-02-15 |
0 |
2013-11-05 |
0 |
Premium* |
|
|
Workday, Inc. |
WDAY |
10% Owner |
2013-04-09 |
0 |
2013-04-10 |
117 |
Premium* |
|
|
Tableau Software Inc |
DATA |
10% Owner |
2013-05-22 |
0 |
2014-12-02 |
69,572 |
Premium* |
|
|
Interleukin Genetics Inc |
ILIU |
10% Owner |
|
0 |
2016-07-29 |
55,418,811 |
Premium* |
|
|
Epizyme, Inc. |
EPZM |
10% Owner |
2013-06-05 |
0 |
2016-01-12 |
6,261,599 |
Premium* |
|
|
Boingo Wireless Inc |
WIFI |
10% Owner |
2013-08-21 |
0 |
2013-12-11 |
0 |
Premium* |
|
|
Glycomimetics Inc |
GLYC |
10% Owner |
|
0 |
2018-05-10 |
9,089,041 |
Premium* |
|
|
Care.com Inc |
CRCM |
10% Owner |
2014-01-29 |
0 |
2017-11-06 |
290 |
Premium* |
|
|
Roka Bioscience, Inc. |
ROKA |
10% Owner |
|
0 |
2014-07-22 |
3,216,810 |
Premium* |
|
|
Loxo Oncology, Inc. |
LOXO |
10% Owner |
2014-08-06 |
0 |
2014-08-06 |
1,789,420 |
Premium* |
|
|
Viracta Therapeutics Ord Shs |
VIRX |
10% Owner |
2014-08-08 |
0 |
2014-08-29 |
4,659,333 |
Premium* |
|
|
Ardelyx Inc |
ARDX |
10% Owner |
2014-12-23 |
0 |
2019-12-09 |
6,564,816 |
Premium* |
|
|
Box Inc |
BOX |
10% Owner |
|
0 |
2015-01-28 |
0 |
Premium* |
|
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2015-02-04 |
0 |
2016-11-29 |
2,758,039 |
Premium* |
|
|
Champions Biotechnology Inc |
CSBR |
10% Owner |
|
0 |
2015-03-11 |
18,750,000 |
Premium* |
|
|
Supernus Pharmaceuticals Inc |
SUPN |
10% Owner |
2015-06-15 |
0 |
2015-11-11 |
212,650 |
Premium* |
|
|
Nuvelo Inc |
ABIO |
10% Owner |
|
0 |
2018-02-26 |
0 |
Premium* |
|
|
Vitae Pharmaceuticals, Inc |
VTAE |
10% Owner |
2015-07-01 |
0 |
2015-07-01 |
1,171 |
Premium* |
|
|
Synlogic Inc |
SYBX |
10% Owner |
2015-10-05 |
0 |
2018-01-26 |
4,228,940 |
Premium* |
|
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2015-10-20 |
0 |
2015-10-20 |
594,245 |
Premium* |
|
|
Xtera Communications, Inc. |
XCOM |
10% Owner |
|
0 |
2015-11-17 |
971,733 |
Premium* |
|
|
Adaptimmune Therapeutics PLC |
ADAP |
10% Owner |
|
0 |
2018-09-07 |
12,000,000 |
Premium* |
|
|
Senseonics Holdings Inc |
SENS |
10% Owner |
2017-12-08 |
48,377 |
2017-12-08 |
30,888,266 |
Premium* |
|
|
Aveo Pharmaceuticals Inc |
AVEO |
10% Owner |
|
0 |
2019-04-08 |
25,243,865 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
|
0 |
2016-12-19 |
5,215,128 |
Premium* |
|
|
Ra Pharmaceuticals, Inc. |
RARX |
10% Owner |
2016-10-31 |
0 |
2016-10-31 |
3,490,073 |
Premium* |
|
|
Cascadian Therapeutics, Inc |
CASC |
10% Owner |
|
0 |
2018-03-09 |
0 |
Premium* |
|
|
Mulesoft, Inc |
MULE |
10% Owner |
|
0 |
2018-05-01 |
0 |
Premium* |
|
|
Mersana Therapeutics, Inc. |
MRSN |
10% Owner |
2017-07-03 |
0 |
2017-07-03 |
8,140,138 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
|
0 |
2019-05-07 |
2,052,454 |
Premium* |
|
|
Surface Oncology, Inc. |
SURF |
10% Owner |
2018-04-23 |
0 |
2018-04-23 |
3,312,877 |
Premium* |
|
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
10% Owner |
2017-10-10 |
0 |
2017-10-10 |
4,909,956 |
Premium* |
|
|
Appian Corp |
APPN |
10% Owner |
2017-11-20 |
0 |
2018-02-13 |
1,167 |
Premium* |
|
|
Liquidia Technologies Inc |
LQDA |
10% Owner |
2018-07-30 |
0 |
2018-07-30 |
2,484,870 |
Premium* |
|
|
Elastic N.v. |
ESTC |
10% Owner |
2018-10-10 |
0 |
2018-10-10 |
2,197,503 |
Premium* |
|
|
Genocea Biosciences, Inc. |
GNCA |
10% Owner |
2019-02-14 |
0 |
2019-06-24 |
7,225,676 |
Premium* |
|
|
Trevi Therapeutics, Inc. |
TRVI |
10% Owner |
2019-05-09 |
0 |
2019-05-09 |
4,438,562 |
Premium* |
|
|
Mirum Pharmaceuticals, Inc. |
MIRM |
10% Owner |
2019-07-22 |
0 |
2019-07-22 |
4,186,243 |
Premium* |
|
|
Oyster Point Pharma, Inc. |
OYST |
10% Owner |
|
0 |
2019-10-30 |
322,458 |
Premium* |
|
|
Sprout Social, Inc. |
SPT |
Director |
2023-05-22 |
16,873 |
2023-05-22 |
99,246 |
Premium* |
|
|
Revolution Acceleration Acquisit... |
BGRY |
|
2023-07-20 |
0 |
2021-09-27 |
0 |
Premium* |
|
|
Nextnav Inc. |
NN |
Director |
2022-06-22 |
57,282 |
2021-12-27 |
0 |
Premium* |
|
|
Zerofox Holdings Ord Shs |
ZFOX |
Director |
2022-12-14 |
42,918 |
2022-12-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
483 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 20
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARDM |
Aradigm Corp |
10% Owner |
– – • |
2003-12-11 |
4 |
A |
$0.00 |
$0 |
I/I |
4,941 |
4,941 |
|
- |
|
| WTKND |
Welltek Incorporated |
Former 10% Owner |
– – – |
2004-09-28 |
4 |
A |
$0.00 |
$0 |
I/I |
14,470 |
14,470 |
|
- |
|
| FOXH |
FoxHollow Technologies |
Former 10% Owner |
– – – |
2004-11-02 |
4 |
A |
$0.00 |
$0 |
I/I |
1,804,462 |
1,804,462 |
|
- |
|
| GYRE |
Gyre Therapeutics |
10% Owner |
– – • |
2006-04-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,913,512 |
3,263,512 |
|
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
– – • |
2006-05-15 |
4 |
A |
$0.00 |
$0 |
I/I |
3,746,869 |
3,746,859 |
|
- |
|
| VG |
Vonage Holdings Corp |
Director |
– • • |
2006-05-30 |
4 |
A |
$0.00 |
$0 |
I/I |
27,930,422 |
6,838,051 |
|
- |
|
| VG |
Vonage Holdings Corp |
Director |
– • • |
2006-05-30 |
4/A |
A |
$0.00 |
$0 |
I/I |
3,841,551 |
21,092,371 |
0 |
- |
|
| VG |
Vonage Holdings Corp |
Director |
– • • |
2006-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
3,750 |
|
- |
|
| VG |
Vonage Holdings Corp |
Director |
– • • |
2006-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
7,500 |
0 |
- |
|
| VG |
Vonage Holdings Corp |
Director |
– • • |
2007-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
11,250 |
0 |
- |
|
| VG |
Vonage Holdings Corp |
Director |
– • • |
2007-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
15,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
10% Owner |
– – • |
2007-06-05 |
4 |
A |
$0.00 |
$0 |
I/I |
4,472,224 |
821,736 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
10% Owner |
– – • |
2007-07-25 |
4 |
A |
$11.49 |
$338,452 |
I/I |
29,447 |
851,183 |
0 |
- |
|
| VG |
Vonage Holdings Corp |
Director |
– • • |
2007-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
18,750 |
0 |
- |
|
| INWK |
Innerworkings Inc |
Director |
– • • |
2007-10-10 |
4 |
A |
$0.00 |
$0 |
I/I |
9,999 |
9,999 |
0 |
- |
|
| IQNT |
Inteliquent Inc |
Director |
– • • |
2007-11-07 |
4 |
A |
$0.00 |
$0 |
I/I |
6,930,194 |
6,930,194 |
0 |
- |
|
| INWK |
Innerworkings Inc |
Director |
– • • |
2007-11-09 |
4 |
A |
$0.00 |
$0 |
I/I |
3,051 |
2,213 |
0 |
- |
|
| VG |
Vonage Holdings Corp |
Director |
– • • |
2007-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
22,500 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
10% Owner |
– – • |
2008-01-17 |
4 |
A |
$7.07 |
$9,191,000 |
I/I |
1,300,000 |
4,563,512 |
0 |
- |
|
| VG |
Vonage Holdings Corp |
Director |
– • • |
2008-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
26,250 |
0 |
- |
|
| VG |
Vonage Holdings Corp |
Director |
– • • |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,750 |
35,000 |
0 |
- |
|
| VG |
Vonage Holdings Corp |
Director |
– • • |
2008-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
42,500 |
0 |
- |
|
| VG |
Vonage Holdings Corp |
Director |
– • • |
2009-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
50,000 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
– – • |
2009-01-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,103,283 |
1,103,283 |
0 |
- |
|
| IQNT |
Inteliquent Inc |
Director |
– • – |
2009-02-24 |
4/A |
A |
$0.00 |
$0 |
I/I |
3,169 |
3,169 |
0 |
- |
|
483 Records found
|
|
Page 1 of 20 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
